Click to copy
Click to copy
Related topics

Intra-Cellular: 2Q Earnings Snapshot

August 7, 2019

NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Wednesday reported a loss of $37.4 million in its second quarter.

On a per-share basis, the New York-based company said it had a loss of 68 cents.

Intra-Cellular shares have declined 24% since the beginning of the year. The stock has fallen 59% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ITCI at https://www.zacks.com/ap/ITCI

All contents © copyright 2019 The Associated Press. All rights reserved.